Details of the Drug

General Information of Drug (ID: DM3HSYC)

Drug Name

CRS-100

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00327652) Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases. U.S. National Institutes of Health.